2022
当前位置:首页  科研成果  发表文章  2022

220. Y. Zheng*, Z.Y. Zhong*, Roadmap to next-generation cancer vaccines, J. Control. Release 2022, 347, 308-313.220.pdf

219. J.J. Wei, D. Wu, Y. Shao, B.B. Guo, J.J. Jiang, J. Chen, J.P. Zhang, F.H. Meng*, Z.Y. Zhong*, ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy, J. Control. Release 2022, 347, 68-77.219.pdf

218. B.B. Guo, J.J. Wei, J.Y. Wang, Y.P. Sun, J.D. Yuan, and Z.Y. Zhong*, F.H. Meng*, CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy, Acta Biomaterialia 2022, 145, 200-209.218.pdf

217. H. Zheng, B.B. Guo, X.Y. Qiu, Y.F. Xia, Y. Qu, L. Cheng*, F.H. Meng*, Z.Y. Zhong*, Polymersome-Mediated Cytosolic Delivery of Cyclic Dinucleotide STING Agonist Enhances Tumor Immunotherapy, Bioactive Mater. 2022, 16, 1-11.217.pdf

216. J.J. Wei, D. Wu, S.S. Zhao, Y. Shao, Y.F. Xia, F.H. Meng*, D.W. Ni, X.Y. Qiu, J.P. Zhang, J. Chen*, and Z.Y. Zhong*, Immunotherapy of Malignant Glioma by Non-Invasive Administration of TLR9 Agonist CpG Nano-immunoadjuvant, Adv. Sci. 2022, 202103689.216.pdf

215.H.H. Fang, Y.J. Sha, L. Yang, J.J. Jiang, L.C. Yin, J.Y. Li, B. Li, B. Klumperman, Z.Y. Zhong*, and F.H. Meng*, Macrophage-Targeted Hydroxychloroquine Nanotherapeutics for Rheumatoid Arthritis Therapy, ACS Appl. Mater. Interfaces 2022, 14, 8824-8837.215.pdf

214.S.J. Yue, Y.F. Zhang, Y.H. Wei, R. Haag, H.L. Sun*, and Z.Y. Zhong*, Cetuximab-Polymersome-Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers, Biomacromolecules 2022, 23, 100-111.214.pdf

213.Y.F. Zhang, J.N. An, Y. Shao, N. Yu, S.J. Yue, H.L. Sun*, J.B. Zhang, W.X. Gu, Y.F. Xia, J.P. Zhang, Y. Xu*, and Z.Y. Zhong*, CD38-Directed Vincristine Nanotherapy for Acute Lymphoblastic Leukemia, Biomacromolecules 2022, 23, 377-387.213.pdf

212.Z. Wang, S.S. Zhao, F.H. Meng*, J.D. Yuan, and Z.Y. Zhong*, Folate-mediated targeted PLK1 inhibition therapy for ovarian cancer: A comparative study of molecular inhibitors and siRNA therapeutics, Acta Biomaterialia 2022, 138, 443-452.212.pdf

211.X.Y. Qiu, Y. Qu, B.B. Guo, H. Zheng, F.H. Meng*, and Z.Y. Zhong*, Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer, J. Control. Release 2022, 341, 498-510.211.pdf